腹部大手术患者个体化围术期血压管理:IMPROVE-multi随机临床试验
这项随机单盲临床试验在15家德国大学医院纳入45岁及以上、择期全身麻醉腹部大手术且预计≥90分钟、具有至少1项高危因素的患者,比较基于术前夜间平均MAP的个体化围术期血压管理与常规MAP≥65 mmHg管理。主要复合终点(术后7天内急性肾损伤、急性心肌损伤、非致命性心脏骤停或死亡)发生率个体化组33.5% vs 常规组30.5%(RR 1.10,95%CI 0.93-1.30;P=0.31),22项次要终点均无显著差异。
要点
- 个体化血压管理未降低术后7天急性肾损伤、心肌损伤、非致命性心脏骤停或死亡的复合终点(33.5% vs 30.5%;RR 1.10,95%CI 0.93-1.30;P=0.31)。
- 22项次要终点均无显著差异,包括术后7天感染并发症(15.9% vs 17.1%;P=0.63)。
- 90天肾脏替代治疗、心肌梗死、非致命性心脏骤停或死亡复合终点为5.7% vs 3.5%(P=0.12),未达统计学显著。
核心结论
- 在高危腹部大手术患者中,以术前夜间平均MAP为目标的个体化围术期血压管理,与MAP≥65 mmHg的常规管理相比,未降低术后7天内急性肾损伤、急性心肌损伤、非致命性心脏骤停或死亡的复合终点发生率(33.5% vs 30.5%;RR 1.10,95%CI 0.93-1.30;P=0.31)。
研究设计与样本
- 随机单盲临床试验,于2023年2月26日至2024年4月25日在15家德国大学医院纳入45岁及以上、择期全身麻醉腹部大手术预计≥90分钟且至少1项高危因素的患者,末次随访日期为2024年7月25日。
- 共入组1272例,随机1142例(每组571例),主要分析纳入1134例(中位年龄66岁,IQR 59-73岁;女性34.1%)。
- 干预为个体化围术期血压管理(基于自动化血压监测评估的术前夜间平均MAP设定目标)与常规血压管理(MAP目标≥65 mmHg)按1:1随机分配。
主要发现
- 主要复合终点(术后7天内急性肾损伤、急性心肌损伤、非致命性心脏骤停或死亡)个体化组190/567例(33.5%)vs 常规组173/567例(30.5%),RR 1.10(95%CI 0.93-1.30),P=0.31。
- 术后7天内感染并发症个体化组90/567例(15.9%)vs 常规组97/567例(17.1%),P=0.63。
- 术后90天内肾脏替代治疗、心肌梗死、非致命性心脏骤停或死亡复合终点个体化组32/566例(5.7%)vs 常规组20/567例(3.5%),P=0.12,未达统计学显著。
- 22项次要终点均无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Intraoperative hypotension is associated with organ injury. However, it remains unknown if targeted blood pressure management during surgery can improve clinical outcomes. OBJECTIVE: To evaluate whether individualized vs routine perioperative blood pressure management during major abdominal surgery improves clinical outcomes in patients considered at high risk of postoperative complications. DESIGN, SETTING, AND PARTICIPANTS: This randomized single-blind clinical trial enrolled patients 45 years or older undergoing elective major abdominal surgery with general anesthesia expected to last 90 minutes or longer who had at least 1 additional high-risk criterion between February 26, 2023, and April 25, 2024, at 15 German university hospitals. The date of last follow-up was July 25, 2024. INTERVENTION: Patients were randomized in a 1:1 ratio to individualized perioperative blood pressure management (with mean arterial pressure [MAP] targets based on preoperative mean nighttime MAP assessed using automated blood pressure monitoring) or routine blood pressure management with a MAP target of 65 mm Hg or higher. MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of a composite outcome of acute kidney injury, acute myocardial injury, nonfatal cardiac arrest, or death within the first 7 postoperative days. There were 22 secondary outcomes, including infectious complications within the first 7 postoperative days and a composite outcome of need for kidney replacement therapy, myocardial infarction, nonfatal cardiac arrest, or death within 90 days after surgery. RESULTS: Of the 1272 patients enrolled, 1142 were randomized (571 patients to each group), and 1134 were included in the primary analysis (median age, 66 years [IQR, 59-73 years]; 34.1% female). The primary outcome occurred in 190 of 567 patients (33.5%) assigned to individualized blood pressure management and 173 of 567 patients (30.5%) assigned to routine blood pressure management (relative risk, 1.10 [95% CI, 0.93-1.30]; P = .31). None of the 22 secondary outcomes were significantly different, including infectious complications within the first 7 postoperative days (90/567 [15.9%] vs 97/567 [17.1%]; P = .63) and a composite outcome of need for kidney replacement therapy, myocardial infarction, nonfatal cardiac arrest, or death within 90 days after surgery (32/566 [5.7%] vs 20/567 [3.5%]; P = .12). CONCLUSIONS AND RELEVANCE: Among patients at high risk of postoperative complications undergoing major abdominal surgery, individualized perioperative blood pressure management with MAP targets based on preoperative mean nighttime MAP did not decrease the composite outcome of acute kidney injury, acute myocardial injury, nonfatal cardiac arrest, or death within the first 7 postoperative days compared with routine blood pressure management with a MAP target of 65 mm Hg or higher. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05416944.
引用
- Saugel B, Meidert AS, Brunkhorst FM, et al. Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial. JAMA. 2025. PMID: 41076588. doi:10.1001/jama.2025.17235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。